Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (311-320 of 607) with videos related to

Pageof 61
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
QJM : Monthly Journal of the Association of Physicians|July 3, 2007
Scleroderma renal crisis: patient characteristics and long-term outcomesH Penn, A J Howie, E J Kingdon, et al.
Journal of Cell Science|October 2, 2008
Loss of protein kinase Cepsilon results in impaired cutaneous wound closure and myofibroblast functionAndrew Leask, Xu Shi-Wen, Korsa Khan, et al.
Rheumatology (Oxford, England)|April 12, 2006
Angiographically proven coronary artery disease in sclerodermaM R Akram, C E Handler, M Williams, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Clinical Investigation|September 20, 2008
GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanismMohit Kapoor, Shangxi Liu, Xu Shi-wen, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 22, 2009
Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantationB Sivakumar, N Haloob, A Puri, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Rheumatology (Oxford, England)|January 3, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysisNina R Goldman, Svetlana I Nihtyanova, Claire F Beesley, et al.
Pageof 61

Showing results (311-320 of 607) with videos related to

Sort By:
Pageof 61
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
QJM : Monthly Journal of the Association of Physicians|July 3, 2007
Scleroderma renal crisis: patient characteristics and long-term outcomesH Penn, A J Howie, E J Kingdon, et al.
Journal of Cell Science|October 2, 2008
Loss of protein kinase Cepsilon results in impaired cutaneous wound closure and myofibroblast functionAndrew Leask, Xu Shi-Wen, Korsa Khan, et al.
Rheumatology (Oxford, England)|April 12, 2006
Angiographically proven coronary artery disease in sclerodermaM R Akram, C E Handler, M Williams, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Clinical Investigation|September 20, 2008
GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanismMohit Kapoor, Shangxi Liu, Xu Shi-wen, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 22, 2009
Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantationB Sivakumar, N Haloob, A Puri, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Rheumatology (Oxford, England)|January 3, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysisNina R Goldman, Svetlana I Nihtyanova, Claire F Beesley, et al.
Pageof 61